×

收藏-健康网会员访问记录

网页标题:
×

注册健康网用户

用 户 名:
联 系 人:
性  别:
密  码:
重复密码:
电子邮箱:
邮箱验证码:
固定电话:
传  真:
手  机:
单位名称:
通信地址:
首选栏目:
×

找回密码

  • 1.选择找回方式
  • 2.确认验证信息
  • 3.修改密码
  • 4.修改成功
  • 找回方式:
  • 用 户 名:
  • 手机号码:

 您现在位置:健康网-医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

H2 Receptor Antagonist Market Report(2007)

作者:wangchun   来源:本站原创    点击数:0    更新时间:2007-8-23 10:03:14

[关键字]: H2 Antagonist

健康网讯:

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  June 2007
Format:  Adobe PDF
Price:  US$ 1,600
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052525
E-mail:
bianch@healthoo.com   wuhf@healthoo.com    

Tables of contents

Summary
First part:Categories and their definitions of drugs for peptic ulcer
1 Categories of stomach diseases and the epidemic trend
2 Overview of drugs for peptic ulcer

Second part:Sales statistic in sample hospitals
1 Market scale and growth trend of drugs for stomach diseases
2 Market scale and growth trend of drugs for peptic ulcer in the past 4 years  (2002~2006)
  2.1 Market scale and growth trend
  2.2 Market shares of different categories
  2.3 Market shares of different products belonging to H2 Receptor Antagonists
  2.4 Analysis on key products (H2 Receptor Antagonists) and enterprsies
    Famotidine
    Cimetidine
    Bismuth Potassium Citrate/Ranitidine
    Ranitidine
    Nizatidine

Third part:Sales statistic of retail market for stomach diseases
1 Market shares of different categories for stomach diseases
2 Market shares of different brands in key cities

Forth part:Information of R&D
1 New drugs and trial drugs in world
2 R&D in China
  2.1 List of Domestic marketd products and import procucts
  2.2 Status of application and approval


Appendix
Appendix 1: Reference retail prices of popular stomach drugs
Appendix 2: The products listed in Drug Catalogue of National Basic Medical Insurance
Appendix 3: Infromation of application and approval for stomach drugs


Tables and figures

Table 1 Classification of drugs for peptic ulcer by action mechanism
Table 2 Classification of drugs for peptic ulcer by action progress
Table 3 Market shares of different categories for petic ulcer drugs
Table 4 Sale and growth of different categories of stomach drugs (2002-2006)
Table 5 Sale and growth of drugs for peptic ulcer in sample hospitals (2002-2006)
Table 6 Sale situation of different categories of peptic ulcer drugs (2002-2006)
Table 7 Sales rank of peptic ulcer drugs (2002-2006)
Table 8 Sale and growth of peptic ulcer drugs belonging to H2 receptor antagonists (2002-2006)
Table 9 Maket shares of key peptic ulcer drugs in 2006
Table 10 Maket shares of enterprises producing Famotidine in 2006
Table 11 Maket shares of enterprises producing Cimetidine in 2006
Table 12 Maket shares of enterprises producing Bismuth Potassium Citrate/Ranitidin in 2006
Table 13 Maket shares of enterprises producing Ranitidine in 2006
Table 14 List of enterprises Which recived the approval for Nizatidine
Table 15 Sales rank of retail drugs for gastrointestinal diseases in Shanghai in 2006
Table 16 Sales rank of enterprises in retail market of gastrointestinal drugs in Shanghai in 2006
Table 17 Sales rank of retail drugs for gastrointestinal diseases in Shenyang in 2006
Table 18 Sales rank of enterprises in retail market of gastrointestinal drugs in Shenyang in 2006
Table 19 Sales rank of retail drugs for gastrointestinal diseases in Qingdao in 2006
Table 20 Sales rank of enterprises in retail market of gastrointestinal drugs in Qingdao in 2006
Table 21 The amount of enterprises producing stomach drugs
Table 22 Products under the examination and approval by SFDA
Table 23 Reail prices of polualr stomach drugs
Table 24 List of the products in Drug Catalogue of National Basic Medical Insurance


Figure 1 Market scale and growth trend of drugs for stomach diseases 2002-2006
Figure 2 Sales values of different categories of stomach drugs 2002-2006
Figure 3 Market shares of different categories of stomach drugs 2002-2006
Figure 4 Total sales values of drugs for peptic ulcer 2002-2006
Figure 5 Sales values of different categories of peptic ulcer drugs 2002-2006
Figure 6 Sales share of different categories of peptic ulcer drugs 2002-2006 (Ranking by sales value)
Figure 7 Sales shares of different categories of peptic ulcer drugs 2002-2006 (Ranking by sales amount)
Figure 8 Sales growth of H2 receptor antagonist 2002-2006
Figure 9 Sales values of different H2 receptor antagonists 2002-2006
Figure 10 Sales amounts of different H2 receptor antagonists 2002-2006
Figure 11 Sales shares of different H2 receptor antagonists 2002-2006 (Ranking by sales value)
Figure 12 Sales shares of different H2 receptor antagonists 2002-2006 (Ranking by sales amount)
Figure 13 Market shares of different categories of peptic ulcer drugs in 2006
Figure 14 Market share of H2 receptor antagnists in 2006
Figure 15 Maket shares of enterprises producing Famotidine in 2006
Figure 16 Maket shares of enterprises producing Cimetidine in 2006
Figure 17 Maket shares of enterprises producing Bismuth Potassium Citrate/Ranitidin in 2006
Figure 18 Maket shares of enterprises producing Ranitidine in 2006
Figure 19 Maket shares of enterprises producing Nizatidine in 2006
Figure 21 Shares of different categories of retail drugs for gastrointestinal diseases in Shanghai in 2006
Figure 22 Shares of different categories of retail drugs for gastrointestinal diseases in Shenyang in 2006
Figure 23 Shares of different categories of retail drugs for gastrointestinal diseases in Qingdao in 2006

H2 Receptor Antagonist Market Report(2007)
注册后,我们会为你提供报告样本并为您提供更全面的咨询服务
您的姓名  称谓: 先生女士
手机号码 
验证号码 
电子邮件 
单位名称 

服务热线

  • 联系项目:86-10-68012929-2103
  • 订购报告:86-10-68012929-2121
  • 邮件订购:leigy@healthoo.com